Microarray Expression Profile of Exosomal circRNAs from High Glucose Stimulated Human Renal Tubular Epithelial Cells

References

• Gnudi L, Coward RJM, Long DA. Diabetic nephropathy: perspective on novel molecular mechanisms. Trends Endocrinol Metab. 2016;27(11):820–830. doi:10.1016/j.tem.2016.07.002
   PubMed Web of Science ®Google Scholar
• Liu DW, Liu FX, Li ZY, et al. HNRNPA1-mediated exosomal sorting of miR-483-5p out of renal tubular epithelial cells promotes the progression of diabetic nephropathy-induced renal interstitial fibrosis. Cell Death Dis. 2021;12(3):255. doi:10.1038/s41419-021-03460-x
   PubMed Web of Science ®Google Scholar
• Xiang E, Han B, Zhang Q, et al. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Stem Cell Res Ther. 2020;11(1):336. doi:10.1186/s13287-020-01852-y
   PubMed Web of Science ®Google Scholar
• Wang S, Zhou Y, Zhang Y, et al. Roscovitine attenuates renal interstitial fibrosis in diabetic mice through the TGF-β1/p38 MAPK pathway. Biomed Pharmacother. 2019;115:108895. doi:10.1016/j.biopha.2019.108895
   PubMed Web of Science ®Google Scholar
• Yao Y, Li Y, Zeng X, et al. Losartan alleviates renal fibrosis and inhibits Endothelial-to-Mesenchymal Transition (EMT) under high-fat diet-induced hyperglycemia. Front Pharmacol. 2018;9:1213. doi:10.3389/fphar.2018.01213
   PubMed Web of Science ®Google Scholar
• Du L, Qian X, Li Y, et al. Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy. Acta Pharmacol Sin. 2021;42(2):242–251. doi:10.1038/s41401-020-0450-2
   PubMed Web of Science ®Google Scholar
• Lu Q, Chen YB, Yang H, et al. Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy. Acta Pharmacol Sin. 2019;40(12):1555–1567. doi:10.1038/s41401-019-0244-6
   PubMed Web of Science ®Google Scholar
• Zhong X, Chung ACK, Chen HY, et al. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia. 2013;56(3):663–674. doi:10.1007/s00125-012-2804-x
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology function and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977. doi:10.1126/science.aau6977
   PubMed Web of Science ®Google Scholar
• He C, Zheng S, Luo Y, Wang B. Exosome theranostics: biology and translational medicine. Theranostics. 2018;8(1):237–255. doi:10.7150/thno.21945
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Kang M-H, Jeyaraj M, et al. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells. 2019;8(4):307. doi:10.3390/cells8040307
   PubMed Web of Science ®Google Scholar
• Tikhomirov R, Donnell BR, Catapano F, et al. Exosomes: from potential culprits to new therapeutic promise in the setting of cardiac fibrosis. Cells. 2020;9(3):592. doi:10.3390/cells9030592
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang Q, Liu D, et al. Exosomes: advances, development and potential therapeutic strategies in diabetic nephropathy. Metabolism. 2021;122:154834. doi:10.1016/j.metabol.2021.154834
   PubMed Web of Science ®Google Scholar
• Xu YX, Pu SD, Li X, et al. Exosomal ncRNAs: novel therapeutic target and biomarker for diabetic complications. Pharmacol Res. 2022;178:106135. doi:10.1016/j.phrs.2022.106135
   PubMed Web of Science ®Google Scholar
• Yang J, Liu D, Liu Z. Integration of metabolomics and proteomics in exploring the endothelial dysfunction mechanism induced by serum exosomes from diabetic retinopathy and diabetic nephropathy patients. Front Endocrinol. 2022;13:830466. doi:10.3389/fendo.2022.830466
   PubMed Web of Science ®Google Scholar
• Wu XM, Gao YB, Cui FQ, Zhang N. Exosomes from high glucose-treated glomerular endothelial cells activate mesangial cells to promote renal fibrosis. Biol Open. 2016;5(4):484–491. doi:10.1242/bio.015990
   PubMed Web of Science ®Google Scholar
• Tsai YC, Hung -W-W, Chang W-A, et al. Autocrine exosomal fibulin-1 as a target of MiR-1269b induces epithelial-mesenchymal transition in proximal tubule in diabetic nephropathy. Front Cell Dev Biol. 2021;9:789716. doi:10.3389/fcell.2021.789716
   PubMed Web of Science ®Google Scholar
• Du WW, Zhang C, Yang W, Yong T, Awan FM, Yang BB. Identifying and characterizing circRNA-protein interaction. Theranostics. 2017;7(17):4183–4191. doi:10.7150/thno.21299
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25(8):981–984. doi:10.1038/cr.2015.82
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu J, Ma J, et al. Exosomal circRNAs: biogenesis, effect and application in human diseases. Mol Cancer. 2019;18(1):116. doi:10.1186/s12943-019-1041-z
   PubMed Web of Science ®Google Scholar
• Li B, Sun G, Yu H, Meng J, Wei F. Exosomal circTAOK1 contributes to diabetic kidney disease progression through regulating SMAD3 expression by sponging miR-520h. Int Urol Nephrol. 2022;54(9):2343–2354. doi:10.1007/s11255-022-03139-y
   PubMed Web of Science ®Google Scholar
• Dong Q, Dong L, Wang YX, et al. Circular ribonucleic acid nucleoporin 98 knockdown alleviates high glucose-induced proliferation, fibrosis, inflammation and oxidative stress in human glomerular mesangial cells by regulating the microribonucleic acid −151-3p–high mobility group AT-hook 2 axis. J Diabetes Investig. 2022;13(8):1303–1315. doi:10.1111/jdi.13821
   PubMed Web of Science ®Google Scholar
• Zhu C, Shen K, Zhou W, Wu H, Lu Y. Exosome-mediated circ_0001846 participates in IL-1β-induced chondrocyte cell damage by miR-149-5p-dependent regulation of WNT5B. Clin Immunol. 2021;232:108856. doi:10.18632/oncotarget.8589
   PubMed Web of Science ®Google Scholar
• Bai S, Xiong X, Tang B, et al. Exosomal circ_DLGAP4 promotes diabetic kidney disease progression by sponging miR-143 and targeting ERBB3/NF-κB/MMP-2 axis. Cell Death Dis. 2020;11(11):1008. doi:10.1038/s41419-020-03169-3
   PubMed Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388. doi:10.1038/nature11993
   PubMed Web of Science ®Google Scholar
• Xie H, Ren X, Xin S, et al. Emerging roles of circRNA_001569 targeting miR145 in the proliferation and invasion of colorectal cancer. Oncotarget. 2016;7(18):26680–26691. doi:10.18632/oncotarget.8589
   PubMed Web of Science ®Google Scholar
• Peng F, Gong W, Li S, et al. circRNA_010383 acts as a sponge for miR-135a, and its downregulated expression contributes to renal fibrosis in diabetic nephropathy. Diabetes. 2021;70(2):603–615. doi:10.2337/db20-0203
   PubMed Web of Science ®Google Scholar
• Zhou B, Yu JW. A novel identified circular RNA, circRNA_010567, promotes myocardial fibrosis via suppressing miR-141 by targeting TGF-beta1. Biochem Biophys Res Commun. 2017;487(4):769–775. doi:10.1016/j.bbrc.2017.04.044
   PubMed Web of Science ®Google Scholar
• Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389(10075):1238–1252. doi:10.1016/S0140-6736(16)32064-5
   PubMed Web of Science ®Google Scholar
• Umanath K, Lewis JB. Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis. 2018;71(6):884–895. doi:10.1053/j.ajkd.2017.10.026
   PubMed Web of Science ®Google Scholar
• Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032–2045. doi:10.2215/CJN.11491116
   PubMed Web of Science ®Google Scholar
• Liu H, Feng J, Tang L. Early renal structural changes and potential biomarkers in diabetic nephropathy. Front Physiol. 2022;13:1020443. doi:10.3389/fphys.2022.1020443
   PubMed Web of Science ®Google Scholar
• Gu YY, Lu FH, Huang XR, et al. Non-coding RNAs as biomarkers and therapeutic targets for diabetic kidney disease. Front Pharmacol. 2021;11:583528. doi:10.3389/fphar.2020.583528
   PubMed Web of Science ®Google Scholar
• Hu M, Wu Y, Yang C, et al. Novel long noncoding RNA lnc-URIDS delays diabetic wound healing by targeting Plod1. Diabetes. 2020;69(10):2144–2156. doi:10.2337/db20-0147
   PubMed Web of Science ®Google Scholar
• Friedrichs P, Schlotterer A, Sticht C, et al. Hyperglycaemic memory affects the neurovascular unit of the retina in a diabetic mouse model. Diabetologia. 2017;60(7):1354–1358. doi:10.1007/s00125-017-4254-y
   PubMed Web of Science ®Google Scholar
• Wang H, Huang X, Xu P, et al. Apolipoprotein C3 aggravates diabetic nephropathy in type 1 diabetes by activating the renal TLR2/NF-κB pathway. Metabolism. 2021;119:154740. doi:10.1016/j.metabol.2021.154740
   PubMed Web of Science ®Google Scholar
• Li X, Xu L, Hou X, et al. Advanced oxidation protein products aggravate tubulointerstitial fibrosis through protein kinase C-dependent mitochondrial injury in early diabetic nephropathy. Antioxid Redox Signal. 2019;30(9):1162–1185. doi:10.1089/ars.2017.7208
   PubMed Web of Science ®Google Scholar
• Wang L, Chang JH, Buckley AF, Spurney RF. Knockout of TRPC6 promotes insulin resistance and exacerbates glomerular injury in Akita mice. Kidney Int. 2019;95(2):321–332. doi:10.1016/j.kint.2018.09.026
   PubMed Web of Science ®Google Scholar
• Liu F, Guo J, Qiao Y, et al. MiR-138 plays an important role in diabetic nephropathy through SIRT1-p38-TTP regulatory axis. J Cell Physiol. 2021;236(9):6607–6618. doi:10.1002/jcp.30238
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhao Y, Zhu X, et al. Active vitamin D regulates macrophage M1/M2 phenotypes via the STAT-1-TREM-1 pathway in diabetic nephropathy. J Cell Physiol. 2019;234(5):6917–6926. doi:10.1002/jcp.27450
   PubMed Web of Science ®Google Scholar
• Wu L, Liu C, Chang D, et al. The Attenuation of diabetic nephropathy by annexin A1 via regulation of lipid metabolism through the AMPK/PPARα/CPT1b pathway. Diabetes. 2021;70(10):2192–2203. doi:10.2337/db21-0050
   PubMed Web of Science ®Google Scholar
• Lucas O, Mas S, Marín-Royo G, et al. Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities. Int J Mol Sci. 2020;21(7):2632. doi:10.3390/ijms21072632
   PubMed Web of Science ®Google Scholar
• Jankowski E, Wulf S, Ziller N, Wolf G, Loeffler I. MORG1-A negative modulator of renal lipid metabolism in murine diabetes. Biomedicines. 2021;10(1):30. doi:10.3390/biomedicines10010030
   PubMed Web of Science ®Google Scholar
• Yang W, Luo Y, Yang S, et al. Ectopic lipid accumulation: potential role in tubular injury and inflammation in diabetic kidney disease. Clin Sci. 2018;132(22):2407–2422. doi:10.1042/CS20180702
   Web of Science ®Google Scholar
• Zheng GS, Tan YM, Shang YY, et al. CIDEC silencing attenuates diabetic nephropathy via inhibiting apoptosis and promoting autophagy. J Diabetes Investig. 2021;12(8):1336–1345. doi:10.1111/jdi.13534
   PubMed Web of Science ®Google Scholar
• Sun W, Wang Y, Miao X, et al. Renal improvement by zinc in diabetic mice is associated with glucose metabolism signaling mediated by metallothionein and Akt, but not Akt2. Free Radic Biol Med. 2014;68:22–34. doi:10.1016/j.freeradbiomed.2013.11.015
   PubMed Web of Science ®Google Scholar
• Dieter C, Assmann TS, Costa AR, et al. MiR-30e-5p and MiR-15a-5p expressions in plasma and urine of type 1 diabetic patients with diabetic kidney disease. Front Genet. 2019;10:563. doi:10.3389/fgene.2019.00563
   PubMed Web of Science ®Google Scholar
• Zhang D, Chen X, Zheng D. A novel MIR503HG/miR-497-5p/CCL19 axis regulates high glucose-induced cell apoptosis, inflammation, and fibrosis in human HK-2 cells. Appl Biochem Biotechnol. 2022;194(5):2061–2076. doi:10.1007/s12010-021-03776-6
   PubMed Web of Science ®Google Scholar